The last earnings report, released on Apr 07, 2026, exceeded the consensus estimates by 0%.On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports.
Oxford Biomedica plc has completed 6 stock splits, with the recent split occurring on May 30, 2018.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on LSE (GBX).